Several novel filoviruses have recently been identified in bats, including Lloviu, Bombali, Mengla, and Dehong viruses, but their biological properties and zoonotic potential remain unclear. This study aimed to compare the functional characteristics of envelope glycoproteins (GPs) from bat-derived filoviruses with those of pathogenic filoviruses such as Ebola and Marburg viruses. Using virus-like particles and vesicular stomatitis virus pseudotypes, the authors examined GP-mediated particle formation, antigenicity, cell entry mechanisms, and cell tropism. All bat-derived filovirus GPs supported the formation of filamentous particles and mediated cellular entry via known filovirus attachment factors, including TIM-1 and C-type lectins, although entry efficiency was generally lower than that of Ebola virus GP. Antigenic analyses showed limited cross-reactivity between bat-derived filovirus GPs and antibodies against Ebola or Marburg viruses, though partial neutralization was observed for some GPs. Infection assays revealed that bat-derived filovirus GPs could mediate entry into a broad range of mammalian cells, including human cells, while displaying virus- and host-specific differences.
(MN)
2026年1月20日火曜日
Comparison of the biological properties of bat-derived filovirus envelope glycoproteins
登録:
コメントの投稿 (Atom)
The Antiviral Activity of Equine Mx1 against Thogoto Virus Is Determined by the Molecular Structure of Its Viral Specificity Region
This study investigated the antiviral activity of mammalian Mx1 proteins against Thogoto virus, focusing on the molecular determinants respo...
-
Severe fever with thrombocytopenia syndrome (SFTS) virus poses a major public health threat, with high mortality rates in both humans and ca...
-
Nucleoprotein is important in regulating transcription and replication of Negative-sense RNA viruses. Although the viral RNA-dependent RNA-p...
-
Bornavirus encephalitis is a critical and deadly emerging disease in humans in Germany, caused by Borna disease virus 1 (BoDV-1) and variega...
0 件のコメント:
コメントを投稿